Morpholino

MO2-prdm1a

ID
ZDB-MRPHLNO-050429-1
Name
MO2-prdm1a
Previous Names
  • E2I2 prdm1-MO (1)
  • MO2-prdm1
Target
Sequence
5' - TGGTGTCATACCTCTTTGGAGTCTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
exon 2 - intron 2 splice-blocking MO
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-prdm1a
Phenotype
Phenotype resulting from MO2-prdm1a
Phenotype of all Fish created by or utilizing MO2-prdm1a
Phenotype Fish Conditions Figures
pharyngeal arch 3 decreased object quality, abnormal AB + MO2-prdm1a standard conditions Fig. 3 from LaMonica et al., 2015
pharyngeal arch 4 decreased object quality, abnormal AB + MO2-prdm1a standard conditions Fig. 3 from LaMonica et al., 2015
pharyngeal arch cartilage has fewer parts of type ceratobranchial cartilage, abnormal AB + MO2-prdm1a standard conditions Fig. 3 from LaMonica et al., 2015
neurocranium decreased width, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 5 cartilage absent, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 2 cartilage absent, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 4 cartilage absent, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
embryonic neurocranium morphogenesis disrupted, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
developmental growth decreased rate, abnormal WT + MO2-prdm1a control Fig. 6 from Kamei et al., 2018
developmental growth decreased rate, abnormal WT + MO2-prdm1a oxygen content, hypoxia Fig. 6 from Kamei et al., 2018
neurocranial trabecula shortened, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 3 cartilage absent, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
pectoral fin skeleton aplastic, abnormal WT + MO2-prdm1a standard conditions Fig. 3 with image from Lee et al., 2006
pectoral fin bud hypoplastic, abnormal WT + MO2-prdm1a standard conditions Fig. 3 with image from Lee et al., 2006
developmental growth decreased rate, abnormal WT + MO2-prdm1a hypoxia Fig. 6 from Kamei et al., 2018
cleithrum decreased size, abnormal WT + MO2-prdm1a standard conditions Fig. 3 with image from Lee et al., 2006
ceratohyal cartilage inverted, abnormal WT + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ethmoid cartilage decreased size, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 3 cartilage absent, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
Meckel's cartilage shortened, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
embryonic neurocranium morphogenesis disrupted, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 5 cartilage absent, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 2 cartilage absent, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
neurocranial trabecula shortened, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 4 cartilage absent, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
embryonic viscerocranium morphogenesis disrupted, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
neurocranium decreased thickness, abnormal WT + MO2-mecom + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ethmoid cartilage decreased size, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 3 cartilage absent, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
neurocranial trabecula shortened, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 2 cartilage absent, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 5 cartilage absent, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
embryonic neurocranium morphogenesis disrupted, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
Meckel's cartilage shortened, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
neurocranium decreased thickness, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
ceratobranchial 4 cartilage absent, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
embryonic viscerocranium morphogenesis disrupted, abnormal WT + MO2-prdm16 + MO2-prdm1a standard conditions Fig. 4 with image from Ding et al., 2013
Citations